BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21454207)

  • 1. Jak/Stat pathway in Waldenström's macroglobulinemia.
    Hodge LS; Ansell SM
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):112-4. PubMed ID: 21454207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
    Tao W; Wen F; Zhang H; Liu G
    Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia.
    Hodge LS; Ziesmer SC; Yang ZZ; Secreto FJ; Novak AJ; Ansell SM
    Blood; 2014 Feb; 123(7):1055-8. PubMed ID: 24335105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT signaling in hematological malignancies.
    Vainchenker W; Constantinescu SN
    Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT signal transduction: regulators and implication in hematological malignancies.
    Valentino L; Pierre J
    Biochem Pharmacol; 2006 Mar; 71(6):713-21. PubMed ID: 16426581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tools and methods for studying the Drosophila JAK/STAT pathway.
    Chen Q; Giedt M; Tang L; Harrison DA
    Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the JAK/STAT signaling pathway in the pathogenesis of acute myocardial infarction in rats and its effect on NF-κB expression.
    Zhang S; Liu X; Goldstein S; Li Y; Ge J; He B; Fei X; Wang Z; Ruiz G
    Mol Med Rep; 2013 Jan; 7(1):93-8. PubMed ID: 23128561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancer of Polycomb and the Tip60 complex repress hematological tumor initiation by negatively regulating JAK/STAT pathway activity.
    Bailetti AA; Negrón-Piñeiro LJ; Dhruva V; Harsh S; Lu S; Bosula A; Bach EA
    Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31072879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
    Coskun M; Salem M; Pedersen J; Nielsen OH
    Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.
    Springuel L; Renauld JC; Knoops L
    Haematologica; 2015 Oct; 100(10):1240-53. PubMed ID: 26432382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.
    Manea SA; Manea A; Heltianu C
    Cell Tissue Res; 2010 Apr; 340(1):71-9. PubMed ID: 20217138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
    O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
    Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The JAK/STAT signaling cascade in gastric carcinoma (Review).
    Khanna P; Chua PJ; Bay BH; Baeg GH
    Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics and non-canonical aspects of JAK/STAT signalling.
    Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
    Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
    Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
    Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.